Updated time: 2021-11-08 14:03:56
Pseudaminic acid is found as a component unique to surface glycan and glycoprotein of bacterial pathogens and has been known for participating in crucial bacterial virulence. Therefore, Pse is considered as an attractive target for new therapeutic application over recent years. Glycoconjugate vaccine have been proven to be effective in combating a broad spectrum of diseases, particularly caused by antibiotic resistant bacteria. In this regard, we aim to prepare the Pse-derived glycoconjugate for vaccination through phage tailspike protein (TSP) instead of chemical method, which impede the reproducibility and was time-consuming. Indeed, in the presented study, we utilized the TSP that specifically digested Pse-coated exopolysaccharide (EPS) of Acinetobacter baumannii to form homogenous glycoconjugate. Moreover, the serum boosted by the glycoconjugate represented significant bactericidal activity against antibiotic resistant A.baumannii, indicating the strong antigenicity of Pse. These efforts provide a potent prophylaxis and demonstrate that Pse is a new glycotope for vaccine or immunotherapy development.
In addition, a probe carrying precise bacterial surface Pse detection is urgently demanding on clinic diagnosis. Here, we developed the catalytic residues mutated (inactivated) phage tail-spike protein ΦAB6TSP (I-ΦAB6TSP) that eliminated glycosidase activity but remained Pse binding as the probe. The fluorophore conjugated I-ΦAB6TSP was incubated with suspended bacteria and then measure the fluorescence of pellet. We found that the fluorescent intensity was near proportional to the OD value of Acinetobacter baumannii, Helicobacter pylori and Enterobacter cloacae, indicating that I-ΦAB6TSP is a promising probe for detecting cross-species Pse. This strategy is cost-effective and simple manipulation compared to the conventional methods.
Simple manipulation: ELISA based detection
Cost-effective than conventional methods, such as Mass spectroscopy.
11A-1070820、11A-1090207
TW I731357、US 11103567 B2
- Clinic diagnosis: probe the pse on the surface of bacteria isolated from the patients.
- Treatment: guide the anti-Pse therapy to relief the suffer of Pse-coated bacterial infection.
Shih-Hsiung Wu、I-Ming Lee
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

The application of tail-spike protein to glycoconjugate vaccine preparation and pathogenic bacteria detection